GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genomic Valley Biotech Ltd (BOM:539206) » Definitions » 5-Year Dividend Growth Rate

Genomic Valley Biotech (BOM:539206) 5-Year Dividend Growth Rate : 0.00% (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Genomic Valley Biotech 5-Year Dividend Growth Rate?

Genomic Valley Biotech's Dividends per Share for the three months ended in Dec. 2024 was ₹0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Genomic Valley Biotech's Dividend Payout Ratio for the three months ended in Dec. 2024 was 0.00. As of today, Genomic Valley Biotech's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Genomic Valley Biotech's 5-Year Dividend Growth Rate

For the Biotechnology subindustry, Genomic Valley Biotech's 5-Year Dividend Growth Rate, along with its competitors' market caps and 5-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genomic Valley Biotech's 5-Year Dividend Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genomic Valley Biotech's 5-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Genomic Valley Biotech's 5-Year Dividend Growth Rate falls into.


;
;

Genomic Valley Biotech 5-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Genomic Valley Biotech  (BOM:539206) 5-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Genomic Valley Biotech's Dividend Payout Ratio for the quarter that ended in Dec. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2024 )/ EPS without NRI (Q: Dec. 2024 )
=0/ 0.51
=0.00

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genomic Valley Biotech 5-Year Dividend Growth Rate Related Terms

Thank you for viewing the detailed overview of Genomic Valley Biotech's 5-Year Dividend Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Genomic Valley Biotech Business Description

Traded in Other Exchanges
N/A
Address
4 K.M. Stone, Berri Charra Road, P.O. Tandaheri, Tehsil-Bahadurgarh, Village Kherka Musalman, Jhajjar, HR, IND, 124507
Genomic Valley Biotech Ltd is an India-based company engaged in providing diagnostic services and related business services. It undertakes commercial production of plant tissue cultured plants of different species to feed the genetically improved plant market nationally as well as internationally. The group conducts research in the field of agriculture, plant tissue culture, medical biotechnology, SERI biotechnology, stem cell, food biotechnology, Drone technology, Poly House Construction, and others. It generates revenue from the sale of services.

Genomic Valley Biotech Headlines

No Headlines